These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 165756)

  • 1. Actions of a new muscle relaxant (AH8165) on neuromuscular transmission.
    Post EL; Sokoll MD; Gergis SD; Dretchen KL; Cronnelly R; Long JP
    Anesthesiology; 1975 Mar; 42(3):240-4. PubMed ID: 165756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative neuromuscular effects of lincomycin and clindamycin.
    Rubbo JT; Gergis SD; Sokoll MD
    Anesth Analg; 1977; 56(3):329-32. PubMed ID: 194504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro investigation of a new neuromuscular relaxant, AH8165.
    Hiser PT; Dretchen KL; Kruger GO
    Anesthesiology; 1975 Mar; 42(3):245-53. PubMed ID: 123133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: A new muscle relaxant-AH8165.
    Blogg CE; Savege TM; Simpson JC; Ross LA; Simpson BR
    Proc R Soc Med; 1973 Oct; 66(10):1023-7. PubMed ID: 4271409
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetic analysis of the AH8165-receptor interaction at the mammalian neuromuscular junction.
    Waud BE
    Anesthesiology; 1977 Feb; 46(2):94-6. PubMed ID: 13684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thiol-oxidizing agent diamide increases transmitter release by decreasing calcium requirements for neuromuscular transmission in the frog.
    Carlen PL; Kosower EM; Werman R
    Brain Res; 1976 Nov; 117(2):257-76. PubMed ID: 186154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the neuromuscular blocking effects of BW 403C65 in frog and cat muscle.
    Post EL; Sokoll MD; Gergis SD; Dretchen KL; Cronnelly R
    Br J Anaesth; 1975 Sep; 47(9):929-35. PubMed ID: 1191480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ganglion blocking and vagolytic actions of three short-acting neuromuscular blocking drugs in the cat.
    Marshall IG
    J Pharm Pharmacol; 1973 Jul; 25(7):530-6. PubMed ID: 4147049
    [No Abstract]   [Full Text] [Related]  

  • 9. A new short-acting non-depolarizing muscle relaxant (SZ1677) without cardiovascular side-effects.
    Vizi ES; Tuba Z; Mahó S; Foldes FF; Nagano O; Dóda M; Takagi S; Chaudhry IA; Saubermann AJ; Nagashima H
    Acta Anaesthesiol Scand; 2003 Mar; 47(3):291-300. PubMed ID: 12648195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A philosophy of relaxation. Eleventh annual Baxter-Travenol lecture.
    Churchill-Davidson HC
    Anesth Analg; 1973; 52(4):495-501. PubMed ID: 4352148
    [No Abstract]   [Full Text] [Related]  

  • 11. [The action of non-depolarizing muscle relaxants on nerve terminal of motor endplate--relationship between run-down of endplate potentials and fading tension response].
    Narimatsu E; Iwasaki H; Namiki A
    Masui; 1994 Oct; 43(10):1446-53. PubMed ID: 7815692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postsynaptic inhibition of neuromuscular transmission by trifluoperazine.
    Cheng KC; Lambert JJ; Henderson EG; Smilowitz H; Epstein PM
    J Pharmacol Exp Ther; 1981 Apr; 217(1):44-50. PubMed ID: 6259329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of AH8165: a rapid-acting, short-lasting, competitive neuromuscular blocking drug.
    Brittain RT; Tyers MB
    Br J Anaesth; 1973 Aug; 45(8):837-43. PubMed ID: 4270988
    [No Abstract]   [Full Text] [Related]  

  • 14. Pancuronium bromide and other steroidal neuromuscular blocking agents containing acetylcholine fragments.
    Buckett WR; Hewett CL; Savage DS
    J Med Chem; 1973 Oct; 16(10):1116-24. PubMed ID: 4356139
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical evaluation of a new non-depolarising muscle relaxant.
    Ungerer MJ; Erasmus FR
    S Afr Med J; 1974 Dec; 48(61):2561-4. PubMed ID: 4281529
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blocking of the neuromuscular conduction by decamethylene-bis-pyridinium].
    Danilov AF
    Farmakol Toksikol; 1970; 33(5):536-8. PubMed ID: 4250151
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of mescaline and some of its analogs on cholinergic neuromuscular transmission.
    Ghansah E; Kopsombut P; Malleque MA; Brossi A
    Neuropharmacology; 1993 Feb; 32(2):169-74. PubMed ID: 8383816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine: myoneural activity and interaction with neuromuscular blocking agents.
    Cronnelly R; Dretchen KL; Sokoll MD; Long JP
    Eur J Pharmacol; 1973 Apr; 22(1):17-22. PubMed ID: 4267587
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of three short-acting neuromuscular blocking agents on fast- and slow-contracting muscles of the cat.
    Marshall IG
    Eur J Pharmacol; 1973 Mar; 21(3):299-304. PubMed ID: 4267689
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of lead on neuromuscular transmission in the frog.
    Manalis RS; Cooper GP; Pomeroy SL
    Brain Res; 1984 Feb; 294(1):95-109. PubMed ID: 6320979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.